Previous close | 0.0490 |
Open | 0.0480 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.0480 - 0.0540 |
52-week range | 0.0300 - 0.0600 |
Volume | |
Avg. volume | 269,883 |
Market cap | 8.814M |
Beta (5Y monthly) | 0.55 |
PE ratio (TTM) | 2.70 |
EPS (TTM) | 0.0200 |
Earnings date | 14 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the first quarter ended March 31, 2024, before the stock market opens on Tuesday, May 14, 2024. The Company will hold a conference call with the investment community at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time) tha
CV Sciences, Inc. (PNK:CVSI) Q4 2023 Earnings Call Transcript March 28, 2024 CV Sciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to CV Sciences’ Fourth Quarter and Year-End 2023 Conference. At this time, all participants are […]
CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the year and quarter ended December 31, 2023.